DK1204679T3 - Peptider som indeholder N-substituerede D-aminosyrer til at forhindre associering af Beta-strenge - Google Patents

Peptider som indeholder N-substituerede D-aminosyrer til at forhindre associering af Beta-strenge

Info

Publication number
DK1204679T3
DK1204679T3 DK00949729T DK00949729T DK1204679T3 DK 1204679 T3 DK1204679 T3 DK 1204679T3 DK 00949729 T DK00949729 T DK 00949729T DK 00949729 T DK00949729 T DK 00949729T DK 1204679 T3 DK1204679 T3 DK 1204679T3
Authority
DK
Denmark
Prior art keywords
peptide
beta
strand
substituted
nalpha
Prior art date
Application number
DK00949729T
Other languages
English (en)
Inventor
Kelvin Stott
Original Assignee
Senexis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senexis Ltd filed Critical Senexis Ltd
Application granted granted Critical
Publication of DK1204679T3 publication Critical patent/DK1204679T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00949729T 1999-07-28 2000-07-28 Peptider som indeholder N-substituerede D-aminosyrer til at forhindre associering af Beta-strenge DK1204679T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9917725.5A GB9917725D0 (en) 1999-07-28 1999-07-28 Peptides
PCT/GB2000/002923 WO2001007474A1 (en) 1999-07-28 2000-07-28 Peptides containing n-substituted d-amino acids for preventing beta-strand association

Publications (1)

Publication Number Publication Date
DK1204679T3 true DK1204679T3 (da) 2007-04-02

Family

ID=10858097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00949729T DK1204679T3 (da) 1999-07-28 2000-07-28 Peptider som indeholder N-substituerede D-aminosyrer til at forhindre associering af Beta-strenge

Country Status (13)

Country Link
US (1) US7060671B1 (da)
EP (1) EP1204679B1 (da)
JP (1) JP2003505470A (da)
AT (1) ATE355302T1 (da)
AU (1) AU767396B2 (da)
CA (1) CA2379241A1 (da)
DE (1) DE60033668T2 (da)
DK (1) DK1204679T3 (da)
ES (1) ES2282125T3 (da)
GB (1) GB9917725D0 (da)
NZ (1) NZ516442A (da)
PT (1) PT1204679E (da)
WO (1) WO2001007474A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE453627T1 (de) 1999-07-21 2010-01-15 Univ Pennsylvania Herstellung von verbindungen zur bestimmung der hypoxie
ES2180417B1 (es) * 2001-03-14 2004-05-16 Consejo Superior De Investigaciones Cientificas Nueva proteina sobreexpresada en cancer de prostata.
DE10117281A1 (de) * 2001-04-06 2002-10-24 Inst Molekulare Biotechnologie Peptid zur Diagnose und Therapie der Alzheimer-Demenz
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
EP1380290A1 (en) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-beta structure pathway and its therapeutic relevance
US8114832B2 (en) 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
CA2615028A1 (en) 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Cross-.beta. structure binding compounds
GB2432586B (en) * 2005-11-25 2010-01-13 Univ Open Treatment of neurodegenerative disorders
JP2007217330A (ja) * 2006-02-16 2007-08-30 Dainippon Sumitomo Pharma Co Ltd 新規ペプチド
US8188046B2 (en) 2006-10-16 2012-05-29 University Of South Florida Amyloid beta peptides and methods of use
WO2008106657A2 (en) * 2007-03-01 2008-09-04 Intezyne Technologies, Inc. Encapsulated amyloid-beta peptides
GB0716885D0 (en) * 2007-08-30 2007-10-10 United Arab Emirates Universit Diagnostic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854204A (en) 1995-03-14 1998-12-29 Praecis Pharmaceuticals, Inc. Aβ peptides that modulate β-amyloid aggregation
US6034211A (en) * 1996-06-03 2000-03-07 Kelly; Jeffery W. β-sheet nucleating peptidomimetics
DE19725619A1 (de) 1997-06-17 1998-12-24 Fraunhofer Ges Forschung Peptide als Agonisten und/oder Inhibitoren der Amyloidbildung und Zytotoxizität sowie der Verwendung bei Alzheimer'schen Krankheit, beim Typ II Diabetes mellitus und bei spongiformen Encephalopathien
ES2290023T3 (es) * 1999-03-04 2008-02-16 Praecis Pharmaceuticals Incorporated Moduladores de la agregacion del peptido beta-amiloide que comprenden d-aminoacidos.

Also Published As

Publication number Publication date
GB9917725D0 (en) 1999-09-29
PT1204679E (pt) 2007-05-31
AU6300400A (en) 2001-02-13
DE60033668D1 (de) 2007-04-12
ES2282125T3 (es) 2007-10-16
EP1204679B1 (en) 2007-02-28
JP2003505470A (ja) 2003-02-12
CA2379241A1 (en) 2001-02-01
WO2001007474A1 (en) 2001-02-01
DE60033668T2 (de) 2007-06-21
US7060671B1 (en) 2006-06-13
NZ516442A (en) 2003-10-31
AU767396B2 (en) 2003-11-06
EP1204679A1 (en) 2002-05-15
ATE355302T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
DE60040274D1 (de) Verabreichung von nukleinsäuren und proteinen an zellen
AR019818A1 (es) Un inmunoconjugado de miostatina.
EP2298331A3 (en) Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
EA200700973A1 (ru) Слитый белок, содержащий домен bh3 белка «вh3-только»
UY28641A1 (es) Anticuerpos
ATE355302T1 (de) N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation
ATE338121T1 (de) Von muc-1 abgeleitete peptide
NO20000934L (no) Adipocyttspesifikke proteinhomologer
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
ES2174770T1 (es) Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide.
ATE551048T1 (de) Proteinhydrolysate enthaltende kosmetische zusammensetzungen
DK0948541T3 (da) Analoge af PTHrP
FI961044A0 (fi) Kininogeeni-inhibiittorit
ATE322503T1 (de) Gefrierschutzprotein
DE69834643D1 (de) Adipozyten-spezifische protein homologe
ATE362487T1 (de) N-substituierte l-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation
DK1079849T3 (da) Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning
TR200002101T2 (tr) Dondurulmuş gıda ürünü.
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
BRPI0606445A2 (pt) inibidores de hipersecreÇço de mucina e mÉtodos de uso
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
DK1117682T3 (da) Chi-conotoksin-peptider som inhibitorer af neuronale amintransportere
WO2001009174A3 (en) Plant defensin variants
DK1504036T3 (da) Toxinrelaterede fragmenter af antistoffer med antimikrobiel og antiviral aktivitet